drugset / Trial / NCT01078909
Dose Response Effects of Marine Omega-3 Fatty Acids on Inflammation
Phase 3
Completed
125 enrolled
Penn State University
United States Department of Agriculture (USDA) · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine the lowest effective dose of EPA + DHA (300, 600, 900 and 1,800 mg/day delivered as fish oil supplements) that significantly attenuates the inflammatory response to in vivo and ex vivo endotoxin challenge as measured by the production over time of several inflammatory markers.
Timeline
- Start
- 2011-10
- Primary completion
- 2012-11
- Completion
- 2014-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Eicosapentaenoic acid | Small molecule | 300 mg | — |
| Subject | Eicosapentaenoic acid | Small molecule | 600 mg | — |
| Subject | Eicosapentaenoic acid | Small molecule | 900 mg | — |
| Subject | Eicosapentaenoic acid | Small molecule | 1800 mg | — |